These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8704322)

  • 1. Aclacinomycin X, a novel anthracycline antibiotic produced by Streptomyces galilaeus ATCC 31133.
    Kim HS; Kim YH; Yoo OJ; Lee JJ
    Biosci Biotechnol Biochem; 1996 May; 60(5):906-8. PubMed ID: 8704322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New betaclamycin and aclarubicin analogs obtained by prolonged microbial conversion with an aclarubicin-negative mutant.
    Johdo O; Yoshioka T; Naganawa H; Takeuchi T; Yoshimoto A
    J Antibiot (Tokyo); 1996 Jul; 49(7):669-75. PubMed ID: 8784429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New anthracycline metabolites produced by the aklavinone 11-hydroxylase gene in Streptomyces galilaeus ATCC 31133.
    Kim HS; Hong YS; Kim YH; Yoo OJ; Lee JJ
    J Antibiot (Tokyo); 1996 Apr; 49(4):355-60. PubMed ID: 8641998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Streptomyces peucetius genes for doxorubicin resistance and aklavinone 11-hydroxylase in Streptomyces galilaeus ATCC 31133 and production of a hybrid aclacinomycin.
    Hwang CK; Kim HS; Hong YS; Kim YH; Hong SK; Kim SJ; Lee JJ
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1616-20. PubMed ID: 7492117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the antitumor antibiotic aclacinomycin A].
    Zhang H; Wang D; Xu S; Ye Y; Chen P
    Wei Sheng Wu Xue Bao; 1991 Jun; 31(3):247-50. PubMed ID: 1862654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of aclacinomycin A-non-producing Streptomyces galilaeus (ATCC 31615) mutants.
    Ylihonko K; Hakala J; Niemi J; Lundell J; Mäntsälä P
    Microbiology (Reading); 1994 Jun; 140 ( Pt 6)():1359-65. PubMed ID: 8081501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone.
    Oki T; Yoshimoto A; Matsuzawa Y; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Nov; 33(11):1331-40. PubMed ID: 6941952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AknK is an L-2-deoxyfucosyltransferase in the biosynthesis of the anthracycline aclacinomycin A.
    Lu W; Leimkuhler C; Oberthür M; Kahne D; Walsh CT
    Biochemistry; 2004 Apr; 43(15):4548-58. PubMed ID: 15078101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthracycline antibiotic 2-hydroxyaclacinomycins. I. 2-Hydroxyaclacinomycin-producing recombinant obtained from aclacinomycin-blocked mutants of Streptomyces galilaeus by a technique of protoplast fusion.
    Yoshimoto A; Johdo O; Ishikura T; Takeuchi T
    Jpn J Antibiot; 1991 Mar; 44(3):269-76. PubMed ID: 1880909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial glycosidation of some anthracycline antibiotics by an antibiotic-negative mutant of aclarubicin producer.
    Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1993 Aug; 46(8):1219-31. PubMed ID: 8407584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. I. Isolation and characterization of various blocked mutants.
    Yoshimoto A; Matsuzawa Y; Oki T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Aug; 34(8):951-8. PubMed ID: 6947976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Directed Biosynthesis of Iso-aclacinomycins with Improved Anticancer Activity.
    Hu Y; Zhang Z; Yin Y; Tang GL
    Org Lett; 2020 Jan; 22(1):150-154. PubMed ID: 31829601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid anthracyclines from a genetically engineered Streptomyces galilaeus mutant.
    Kunnari TJ; Ylihonko KP; Klika KD; Mäntsälä PI; Hakala JM
    J Org Chem; 2000 May; 65(10):2851-5. PubMed ID: 10814169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of aklavinone and aclacinomycins in vitro and in vivo by rhodomycin biosynthesis gene products.
    Wang Y; Niemi J; Mäntsälä P
    FEMS Microbiol Lett; 2002 Feb; 208(1):117-22. PubMed ID: 11934504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering anthracycline biosynthesis toward angucyclines.
    Metsä-Ketelä M; Palmu K; Kunnari T; Ylihonko K; Mäntsälä P
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1291-6. PubMed ID: 12654660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. II. Structure of new anthracycline antibiotics obtained by microbial glycosidation and biological activity.
    Matsuzawa Y; Yoshimoto A; Oki T; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Nov; 33(11):1341-7. PubMed ID: 6941953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A gene cluster from Streptomyces galilaeus involved in glycosylation of aclarubicin.
    Räty K; Kunnari T; Hakala J; Mäntsälä P; Ylihonko K
    Mol Gen Genet; 2000 Sep; 264(1-2):164-72. PubMed ID: 11016846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730.
    Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1991 Oct; 44(10):1121-9. PubMed ID: 1955395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. II. Structure of 2-hydroxyaklavinone and new aklavinone glycosides.
    Matsuzawa Y; Yoshimoto A; Shibamoto N; Tobe H; Oki T; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Aug; 34(8):959-64. PubMed ID: 7319928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor anthracycline antibiotics, aclacinomycin A and analogues. I. Taxonomy, production, isolation and physicochemical properties.
    Oki T; Kitamura I; Yoshimoto A; Matsuzawa Y; Shibamoto N; Ogasawara T; Inui T; Takamatsu A; Takeuchi T; Masuda T; Hamada M; Suda H; Ishizuka M; Sawa T; Umezawa H
    J Antibiot (Tokyo); 1979 Aug; 32(8):791-800. PubMed ID: 500500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.